RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 76 filers reported holding RECRO PHARMA INC in Q1 2021. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,097 | -57.4% | 13,000 | 0.0% | 0.00% | -57.1% |
Q2 2023 | $14,300 | -7.6% | 13,000 | 0.0% | 0.01% | -30.0% |
Q1 2023 | $15,470 | -20.1% | 13,000 | 0.0% | 0.01% | -9.1% |
Q4 2022 | $19,370 | -7.8% | 13,000 | 0.0% | 0.01% | 0.0% |
Q3 2022 | $21,000 | +110.0% | 13,000 | 0.0% | 0.01% | +120.0% |
Q2 2022 | $10,000 | -56.5% | 13,000 | 0.0% | 0.01% | -44.4% |
Q1 2022 | $23,000 | +4.5% | 13,000 | 0.0% | 0.01% | +12.5% |
Q4 2021 | $22,000 | -18.5% | 13,000 | 0.0% | 0.01% | -46.7% |
Q3 2021 | $27,000 | -6.9% | 13,000 | 0.0% | 0.02% | +15.4% |
Q2 2021 | $29,000 | -19.4% | 13,000 | 0.0% | 0.01% | -27.8% |
Q1 2021 | $36,000 | -2.7% | 13,000 | 0.0% | 0.02% | -5.3% |
Q4 2020 | $37,000 | +37.0% | 13,000 | 0.0% | 0.02% | +11.8% |
Q3 2020 | $27,000 | -54.2% | 13,000 | 0.0% | 0.02% | -60.5% |
Q2 2020 | $59,000 | -44.3% | 13,000 | 0.0% | 0.04% | -57.4% |
Q1 2020 | $106,000 | – | 13,000 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samjo Capital LLC | 8,039,100 | $3,770,338 | 1.48% |
First Light Asset Management, LLC | 19,676,396 | $9,228,230 | 0.88% |
AWM Investment Company, Inc. | 10,266,144 | $4,814,822 | 0.71% |
Caligan Partners LP | 1,689,768 | $794,191 | 0.36% |
HighMark Wealth Management LLC | 484,985 | $227,458 | 0.19% |
Nantahala Capital Management | 1,250,000 | $586,250 | 0.05% |
Clear Harbor Asset Management, LLC | 938,847 | $440,319 | 0.05% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 4,249,229 | $1,992,888 | 0.03% |
TITLEIST ASSET MANAGEMENT, LLC | 210,148 | $98,559 | 0.02% |
ROYCE & ASSOCIATES LP | 3,285,082 | $1,540,703 | 0.02% |